Skip to main content
. 2024 Jun 1;14:12618. doi: 10.1038/s41598-024-63041-8

Figure 3.

Figure 3

Perfusion system used for loading and recovery, and detailed supercooling protocol. (a) Perfusion system. (i) The VCA is placed on a rack inside a stainless-steel bowl containing the perfusate solution. (ii) A peristaltic pump generates a flow in the silicon tubing to reach (iv) the Hollow-fiber membrane oxygenator, which also traps potential air bubbles. (v) A pressure sensor is connected to the closed system and to (iii) a pressure monitor, allowing for continuous monitoring. (vi) The oxygenated perfusate reaches the VCA through the arterial cannula. (vii) A hot plate stirrer keeps the perfusate at the desired temperature. White arrow = thermometer. (b) Supercooling protocol. The VCA is first loaded with 3-OMG as an intracellular CPA using SNMP (21 °C), before incremental switching to the extracellular CPA cocktail while decreasing the temperature until reaching 4 °C. The limb is then placed for 48 h in a sterile bag full of the extracellular CPA cocktail at − 5 °C in a cooler. The recovery is performed using SNMP with normal Steen + solution with incremental unloading of the extracellular CPA during gradual rewarming. The SNMP is pursued 2 h before switching to whole autologous blood warmed at 37 °C to perform the 2 h NMP phase. 3-OMG 3-O-methyl-glucose, CPA cryoprotective agent, HTK histidine-tryptophan-ketoglutarate, NMP normothermic machine perfusion, PEG polyethylene glycol, SNMP subnormothermic machine perfusion.